XML 30 R19.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2019
Accounting Policies [Abstract]  
Summary of Reconciliation of Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the condensed balance sheets that sum to the total of the same amounts shown in the condensed statements of cash flows.

 

 

 

March 31,

2019

 

 

December 31,

2018

 

Cash and cash equivalents

 

$

9,233,559

 

 

$

6,540,794

 

Restricted cash

 

 

75,000

 

 

 

75,000

 

Total cash, cash equivalents, and restricted cash

 

$

9,308,559

 

 

$

6,615,794

 

Summary of Accounts Payable and Other Accrued Expenses

Accounts Payable and Other Accrued Expenses:

 

 

 

March 31,

2019

 

 

December 31,

2018

 

Trade payables

 

$

525,624

 

 

$

426,727

 

Accrued compensation and benefits

 

 

470,974

 

 

 

1,027,757

 

Accrued directors fees

 

 

23,750

 

 

 

 

Other

 

 

290,081

 

 

 

288,943

 

 

 

$

1,310,429

 

 

$

1,743,427

 

Summary of Revenue by Major Source

The following table presents revenue by major source:

 

 

 

March 31,

2019

 

O&P providers

 

$

650,664

 

Direct to patient

 

 

179,402

 

Total revenue from contracts with customer

 

$

830,066

 

 

Summary of Potential Common Shares Issuable

Potential common shares issuable consist of the following at:

 

 

 

March 31,

 

 

 

2019

 

 

2018

 

Stock options

 

 

723,746

 

 

 

573,504

 

Restricted stock units

 

 

33,126

 

 

 

40,001

 

Restricted stock

 

 

27,883

 

 

 

26,876

 

Stock warrants

 

 

5,071,887

 

 

 

5,073,887

 

Total

 

 

5,856,642

 

 

 

5,714,268